Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2806_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
20 Мб
Скачать
72
HRQOL
instrument
used
signicantly better in the
younger group, whereas
Main ndings related to
HRQOL
Follow-up
RAND-36 Physical functioning was
completion
rate (%)
emotional health scores
84%
octogenarians and
20±18in the
younger group
were better in the
octogenarian group
M. K. H. Tan et al.
(continued)
Pre-op
No 17±16months in
HRQOL
assessment Follow-up period
Octogenarians average
age was 85years (range
80–91). The younger
group had an average age
Westchester
Medical
Centre,
NewYork,
Comparison of outcomes
following type A
dissection repair in
Study intent and number
of patients Surgical centre Patient characteristics
octogenarians (n=21)
of 60years (range
30–79years)
The two groups had
similar preoperative
characteristics, but the
younger group
experienced signicantly
more malperfusion and
USA
and those aged less than
80 (n=101)
Procedures consisted of
71 ascending/hemiarch
replacements, 22 Bentall
procedures, 2 David
procedures, 4 Wheat
procedures and 2 total
had a signicantly longer
DHCA time
arch replacements
Table 4.7
Author, year of
publication,
study period and
study type
Tang etal. 2013
[1]
2005–2011
Retrospective
cohort study
4 Thoracic Aortic Surgery
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Main ndings related to HRQOL
averaged HRQoL score was signicantly
decreased in patients with DHCA between
HRQOL
instrument used
Follow-up
completion rate
(%)
86.7%
20–34min and in >35min
Averaged HRQoL score was signicantly better
with the use of ACP, independent of the
duration of DHCA
ACP, however, improved averaged HRQoL
score at each time period and allowed DHCA
to be extended up to 30min, without
impairment in mid-term HRQoL
DHCA >20min resulted in signicantly lower
HRQoL than age and gender-matched standard
population in the domains of physical
functioning, social functioning and vitality
HRQoL was superior in patients with thoracic
aortic aneurysms as compared with patients
with acute type A dissections, but this is likely
to be related to the DHCA time and not the
type of the disease
were similar in all three groups and comparable
to age- and sex-matched standard population
Average HRQoL after a DHCA time of
30–50min with CCP through the RSA was
signicantly higher than with selective
ACP—post-op HRQoL without CCP in this
time group was signicantly lower than a
standardized population
HR QoL limitations were mainly in the aspects
of vitality and social and physical function
Eight patients (20.2%) in the CCP group
reported neurological symptoms of the right
arm after cannulation of the right axillary
artery, of which two had conrmed
plexus-related dysfunction of the right arm
80.0%
73
(continued)
Pre-op
HRQOL
assessment Follow-up period
No 2.4±1.2years SF-36 Compared to patients with DHCA of <20min,
Mean age of patients was
60.8±13.3years of whom
74% were male
167 patients had type A
dissection and 187 had an
aortic aneurysm
University
Hospital Berne,
Switzerland
Study intent and number of
patients Surgical centre Patient characteristics
Assessment of the impact of
DHCA duration and the
potential impact of ACP on
mid-term QoL
Total of 363 patients
undergoing surgery of the
thoracic aorta with
DHCA.These were split in to
DHCA times of <20min,
20–29min and30min for
analysis
ACP was used in 41 (11.3%) of
cases
No 2.4±1.2years SF-36 Average HRQoL scores up to 20min of DHCA
Pre-operative
characteristics were
“similar” in all three
groups, although there
were signicantly more
type A dissections in the
group receiving CCP
University
Hospital Berne,
Switzerland
To assess the impact of
continuous cerebral perfusion
via the RSA on immediate
outcome and QoL
Total of 567 consecutive
patients who underwent surgery
of the aortic arch using
DHCA.Divided in to three
groups based on cerebral
protection: 1) 387 patients had
DHCA alone with pentothal, 2)
91 had selective ACP and
pentothal and 3) 89 had CCP
through the RSA and pentothal
Immer etal.
2008 [55]
1994 onwards
Retrospective
Author, year of
publication, study
period and study
type
Immer etal.
2004 [54]
1994–2002
Retrospective
Table 4.8 Studies observing neurological outcomes and cerebral protection
cohort study
cohort study
74
HRQOL
instrument used
Follow-up
Main ndings related to HRQOL
HRQoL after surgery with selective ACP was
“excellent in the long-term”
completion rate
(%)
SIP
questionnaire
82%
months
impaired HRQoL in all aspects except that of
bodily pain when compared to those with no
post-operative TND
In patients which did not suffer from TND, the
results of the SF-36in all eight domains were
within the reported range of age- and
gender-matched population
82%
M. K. H. Tan et al.
Pre-op
HRQOL
assessment Follow-up period
No 28 (9–109)
Mean age of
59±12years, 71% male
65% of patients had acute
aortic dissection and 34%
University
Medical Centre
Regensburg,
Germany
Study intent and number of
patients Surgical centre Patient characteristics
Quality of life assessment of 79
undergoing surgery of the
ascending aorta and arch with
DHCA and selective ACP
with aortic aneurysm
71% of operations were
performed on an emergent
basis
11% of patients underwent
a redo procedure
Arterial cannulation was
via the central aorta in
All patients underwent
replacement of the ascending
aorta, combined with hemiarch
(n=33) or total (n=46) arch
replacement
No 27±14months SF-36 Patients with TND showed a signicantly
57%, the femoral in 19%
and the RSA in 24%
290 (31.9%) patients had
type A dissection and 617
had an aortic aneurysm.
In 547 patients (60.3%)
the distal anastomosis was
University
Hospital Berne,
Switzerland
Assessment of the inuence of
TND (confusion, delirium and
agitation with a GCS of <13)
on short- and long-term
outcome in 917 patients who
performed using DHCA
underwent surgery of the
ascending aorta and proximal
arch
Author, year of
Table 4.8 (continued)
publication, study
period and study
type
Kobuch etal.
2012 [56]
1998–2007
Retrospective
cohort
Krähenbühl
etal. 2008 [57]
1996–2005
Retrospective
cohort
HRQOL
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
instrument used
Follow-up
4 Thoracic Aortic Surgery
Main ndings related to HRQOL
duration of DHCA up to 20min and were
within the reported range of age- and
sex-matched standard population
For DHCA >40min, bilateral perfusion
provided superior midterm HRQoL results and
these patients still remained comparable to an
completion rate
(%)
100%
age- and gender-matched standard population
comparable to national reference population
with chronic health conditions
RAND-36 All scores were similar between groups and
88% for
thoracic aortic
surgery
59% for
coronary artery
surgery
(range 5–8) for
thoracic aortic
surgery group
Median 6.3years
(range 4.6–7.8)
for coronary
artery surgery
group
75
Pre-op
HRQOL
assessment Follow-up period
No 23.2±15months SF-36 HRQoL was similar in all four groups for
Mean age was
64±10.6years and 69.8%
were male. 60.2% were
operated on electively and
University
Hospital Berne,
Switzerland
Study intent and number of
patients Surgical centre Patient characteristics
Comparison of three different
cerebral protection techniques
on QoL: DHCA alone (n=12),
SACP (n=133) vs. RAACP
38% presented with type
A dissection
Patient characteristics
were similar in all groups.
Bentall was performed in
43.5% and supracoronary
repair in 56.5%
Patients receiving RAACP
(n=118) vs. RAACCP (n=29)
Total of 292 patients included
who underwent surgery of the
thoracic aorta using DHCA
and RAACCP comprised
of signicantly more
emergency cases with
signicantly longer
DHCA and CPB duration
No Median 6.8years
Thoracic aortic surgery:
• Median age 62years old
(range 30–75)
• 73% male
Coronary artery surgery:
• Median age 64years old
(range 37–80)
• 81% male
Those in the coronary
Helsinki
University
Hospital,
Helsinki,
Finland
Comparison between patients
undergoing thoracic aortic
surgery with hypothermic
circulatory arrest (n=30) vs.
patients undergoing coronary
artery surgery without
hypothermic circulatory arrest
(n=31)
artery surgery group had
higher rates of smoking
history and diabetes, but
had a lower EuroSCORE I
Author, year of
publication, study
period and study
type
Krähenbühl
etal. 2010 [58]
2004–2007
Retrospective
cohort
Stewart etal.
2018 [59]
2007–2011
Prospective
cohort
76
M. K. H. Tan et al.
ods and post-operative neurological injury pre­dicted impaired HRQoL. Advanced cerebral protection methods (e.g. bilateral selective ante­grade cerebral perfusion) improved HRQoL at follow-up.
Krähenbühl et al. looked at the impact of temporary neurological dysfunction (TND; confusion, delirium or agitation) on HRQoL post-operatively. In 917 patients undergoing proximal aortic surgery, 9.8% of patients suf­fered from TND which resulted in signicant impairment of HRQoL in all domains exclud­ing bodily pain. Patients without TND were shown to have comparable HRQoL to the nor­mal population. TND was predicted by older age, pre-operative haemodynamic compromise and the use of DHCA [57]. Prolonged use of DHCA was also associated with poor post­operative HRQoL in two other studies [54, 55], but this was mitigated with various DHCA pro­tection strategies (i.e. selective antegrade cere­bral perfusion [54, 58], right axillary antegrade cerebral perfusion [58], right axillary perfu­sion with an additional catheter in the left carotid artery [58], right subclavian artery con­tinuous cerebral perfusion [55]). Immer etal. for example showed that in 363 consecutive patients having proximal aortic surgery and prolonged DHCA (dened as >20 min), HRQoL at follow-up was impaired compared to a normal population [54]. However, this impairment was not seen when the cerebral perfusion strategies were applied in further studies, with superior mid-term HRQoL which was comparable to the normal population asso­ciated with the use of right subclavian cannula­tion (with continuous and bilateral cerebral protection) [55, 58].
These ndings relating neurological out­comes and cerebral protection to mid- and long-term HRQoL are not surprising. Animal models have shown that 11% of brain activity still remains even when temperatures are decreased to 8 °C, suggesting that if DHCA alone is used, there still remains the possibility of incomplete protection and consequent dif­fuse brain injury [54]. With the addition of ACP
in other animal models, reduced apoptosis in the hippocampus and preserved oxygen tension has been reported [6062]. While the current evidence suggests that right axillary cannula­tion with bilateral continuous cerebral protec­tion appears to be the most effective means of cerebral protection, this must be considered in the context of a high incidence of right arm dys­function (up to 20%) and brachial plexus injury (estimated around 2%) [55].
Discussion
HRQoL has become increasingly important in thoracic aortic surgery, with increased appre­ciation of the differences between patient-cen­tred outcomes and traditional surgical perceptions of what is important [63]. This was recently recognised in a review describing key aspects of HRQoL and patient-reported out­comes measures, including patients being the best judges of the impact of interventions on their symptoms and daily function, provision of a shared clinical decision-making frame­work, and in the improvement of quality and safety [64]. This is particularly important in patients with a high pre-operative HRQoL, with studies in related elds of cardiac surgery [65, 66] showing ceiling effects, suggesting that patients with good HRQoL have little to gain but much to lose with respect to their quality of life.
This chapter has outlined the literature regarding HRQoL after interventions on the thoracic aorta. Most studies, as detailed above, conrm that HRQoL after major surgery (both elective and emergency interventions, as well as in elderly patients) is acceptable and is often comparable to that of a general population. A summary framework shows contributory fac­tors that may impair HRQoL in thoracic aortic surgery (Fig.4.1). This analysis must however be interpreted with recognition of the limita­tions detailed below. Suggestions for future research are also discussed further in this section.
4 Thoracic Aortic Surgery
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Predictors of Impaired HRQoL in Thoracic Aortic Surgery
Proximal Aorta Thoracoabdominal Aorta Endovascular Interventions Cerebral Protection
77
Aortic Root Replacement
• Non-aortic valve sparing aortic root replacement
• Use of mechanical aortic valve
Other Proximal Aortic
Operations
• Emergency surgery
• DHCA use
• Increasing age
• Long hospital stay
Type A Dissection Repair
• More aggressive procedure (ascending aorta + aortic arch repair)
• Patient characteristics: • Fenestrated branched
• Increasing age
• Female gender
• Peripheral vascular disease
• Greater burden of baseline co­ morbidities
• Descending aorta and thoracoabdominal aortic operations
• Any reoperation
Fig. 4.1 Predictors of poor HRQoL in aortic surgery
Study Limitations
In the current literature, majority of studies are retrospective and only one contains an element of randomisation. Differences in baseline demo­graphics and patient characteristics, as high­lighted in the tables where identied, is largely due to this observational design in most studies and the lack of experimental methodology. As previously mentioned, patients with thoracic aor­tic disease tend to have a signicant number of co-morbidities, and the lack of randomisation leads to heterogeneity seen in the current litera­ture. Additionally, while the overall follow-up completion rate was generally high, only two studies reported baseline HRQoL.Together with the lack of uniformity of instruments used and the variety of timepoints used for follow-up, comparisons of outcomes was challenging. This may be improved with initiatives promoting pre­and post-intervention HRQoL collection—the United Kingdom’s Department of Health has started routine collection for a selection of opera­tions which unfortunately does not include tho­racic aorta surgery [7], while the Netherlands has started a national initiative termed ‘Meetbaar Beter’ to encourage cardiothoracic centres to col­lect pre- and post-operative HRQoL [67]. Finally, bias may be an issue given that patients with poor HRQoL are unlikely to respond to surveys, lead-
EVAR use in thoracoabdominal aortic aneurysms (when compared to pararenal aneurysms)
• Prolonged DHCA periods
• Post-operative neurological injury
ing to falsely elevated HRQoL results. Institutions may also contribute to the bias with increased efforts to publish and present positive ndings— notably, a number of studies in the literature orig­inate from the same institution.
Suggestions forFuture Research
HRQoL outcomes are not a new reporting instru­ment in the literature—one of the rst studies to publish on these outcomes was available over 40years ago [68]. Despite this, few randomised controlled trials report such outcomes, with the current literature reviewed in this chapter still only including one randomised trial [11]. Future research into thoracic aortic interventions should include elements of randomisation. As for instru­ment selection, while most studies use generic instruments (e.g. SF-36, RAND-36) that are fre­quently used in all areas of medicine and surgery, there is still no consensus as to which instrument is best for data collection in aortic surgery. Additionally, while a number of disease-specic instruments were used in the current studies, future data collection would be facilitated by a standardised aortic specic common instrument. This standardisation should also be extended to a uniform reporting standard of baseline and post­operative (at predened timepoints) HRQoL
78
Fig. 4.2 Conclusions regarding HRQoL after aortic surgery
M. K. H. Tan et al.
Chapter Conclusions:
• HRQoL after aortic surgery is satisfactory
• Even in elderly and high-risk populations, HRQoL is comparable to healthy age­ and sex-matched individuals
• Aortic surgery should aim to preserve, if not improve, HRQoL especially in elective scenarios where patients are largely asymptomatic
• Available literature on HRQoL in aortic surgery is currently lacking, especially with regards to randomised trials
• Focusing on HRQoL outcomes in future trials will be required to allow for evidence-based policymaking and resource allocation
assessment. This would also be further improved by a consensus set of outcome measures in tho­racic aortic surgery such as those already avail­able through the International Consortium for Health Outcomes Measurement for coronary artery disease and heart failure [69]. Innovation may take the form of correlating HRQoL to patient activity as measured by wrist-worn accel­erometers [70, 71] or biomechanical parameters such as aortic blood ow, shear wall stress and pulse wave velocity [7274].
Conclusions
HRQoL after aortic surgery is generally satisfac­tory and found to be at similar levels (even in elderly and high-risk populations) to healthy age­and sex-matched patients (Fig. 4.2). Baseline characteristics of patients with descending tho­racic aortic disease tend to be poorer, which may be secondary to the multitude of co-morbidities they usually have. Patients undergoing emer­gency operations for type A dissections also often appear to have poorer HRQoL when compared to matched populations. Aortic surgery should aim to preserve or improve HRQoL, especially in elective operations where a good number of patients are asymptomatic, and patients will need to be made aware of HRQoL outcomes as part of the consent process. Despite increasing interest in HRQoL as an outcome measure in aortic sur­gery, there is still only one prospective ran­domised trial in the current literature which studies HRQoL outcomes. Further trials with a
focus on HRQoL outcomes will need to be per­formed to advise evidence-based aortic policy­making and resource allocation in the future.
References
1. Tang GH, Malekan R, Cindy JY, Kai M, Lansman SL, Spielvogel D.Surgery for acute type A aortic dissec­tion in octogenarians is justied. Elsevier; 2013.
2. Isselbacher EM.Thoracic and abdominal aortic aneu­rysms. Circulation. 2005;111(6):816–28.
3. Black JH, Cambria RP.Current results of open surgi­cal repair of descending thoracic aortic aneurysms. J Vasc Surg. 2006;43(2):A6–11.
4. Jarral OA, Kidher E, Patel VM, Nguyen B, Pepper J, Athanasiou T. Quality of life after interven­tion on the thoracic aorta. Eur J Cardiothorac Surg. 2016;49(2):369–89.
5. Baig K, Harling L, Papanikitas J, Attaran S, Ashraan H, Casula R, etal. Does coronary artery bypass graft­ing improve quality of life in elderly patients? Interact Cardiovasc Thorac Surg. 2013;17(3):542–53.
6. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
7. Guidance on the routine collection of Patient Reported Outcome Measures (PROMs). 28.
8. Ramanath VS, Oh JK, Sundt TM, Eagle KA.Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clin Proc. 2009;84(5):465–81.
9. Akhyari P, Bara C, Kodis T, Khaladj N, Haverich A, Klima U. Aortic root and ascending aortic replace­ment. Int Heart J. 2009;50(1):47–57.
10. Bori Bata A-K, D’Ostrevy N, Pereira B, Geoffroy E, Dauphin N, Eljezi V, etal. Valve-sparing aortic root replacement-midterm outcomes and quality of life. Cardiovasc Diagn Ther. 2017;7(6):572–80.
11. El-Hamamsy I, Eryigit Z, Stevens L-M, Sarang Z, George R, Clark L, etal. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised con­trolled trial. Lancet. 2010;376(9740):524–31.
4 Thoracic Aortic Surgery
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
79
12. Franke UF, Isecke A, Nagib R, Breuer M, Wippermann J, Tigges-Limmer K, et al. Quality of life after aortic root surgery: reimplantation technique versus composite replacement. Ann Thorac Surg. 2010;90(6):1869–75.
13. Golczyk K, Kompis M, Englberger L, Carrel TP, Stalder M.Heart valve sound of various mechanical composite grafts, and the impact on patients’ quality of life. J Heart Valve Dis. 2010;19(2):228–32.
14. Khaladj N, Ismail I, Shrestha M, Peterss S, Pichlmaier M, Kallenbach K, etal. Aortic root surgery in combi­nation with hypothermic circulatory arrest: preserve or replace the aortic valve in the context of postopera­tive neurological outcome? A case match comparison. Interact Cardiovasc Thorac Surg. 2009;9(2):246–50.
15. Lehr EJ, Wang PZT, Oreopoulos A, Kanji H, Norris C, Macarthur R.Midterm outcomes and quality of life of aortic root replacement: mechanical vs biological conduits. Can J Cardiol. 2011;27(2):262.e15–20.
16. Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G.Survival and quality of life after aortic root replacement with homografts in acute endocardi­tis. Ann Thorac Surg. 2010;90(6):1862–7.
17. Wachter K, Franke UFW, Yadav R, Nagib R, Ursulescu A, Ahad S, et al. Feasibility and clinical outcome after minimally invasive valve-sparing aortic root replacement. Interact Cardiovasc Thorac Surg. 2017;24(3):377–83.
18. Zacek P, Holubec T, Vobornik M, Dominik J, Takkenberg J, Harrer J, etal. Quality of life after aor­tic valve repair is similar to Ross patients and superior to mechanical valve replacement: a cross-sectional study. BMC Cardiovasc Disord. 2016;2(16):63.
19. Abe T, Terazawa S, Ito H, Tokuda Y, Fujimoto K, Mutsuga M, et al. Clinical outcomes and quality of life after surgery for dilated ascending aorta at the time of aortic valve replacement; wrapping versus graft replacement. Nagoya J Med Sci. 2017;79(4):443–51.
20. Lohse F, Lang N, Schiller W, Roell W, Dewald O, Preusse C-J, etal. Quality of life after replacement of the ascending aorta in patients with true aneurysms. Tex Heart Inst J. 2009;36(2):104–10.
21. Olsson C, Thelin S. Quality of life in survi­vors of thoracic aortic surgery. Ann Thorac Surg. 1999;67(5):1262–7.
22. Song HK, Kindem M, Bavaria JE, Dietz HC, Milewicz DM, Devereux RB, etal. Long-term impli­cations of emergency versus elective proximal aor­tic surgery in patients with Marfan syndrome in the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions Consortium Registry. J Thorac Cardiovasc Surg. 2012;143(2):282–6.
23. Stalder M, Staffelbach S, Immer FF, Englberger L, Berdat PA, Eckstein FS, et al. Aortic root replace­ment does not affect outcome and quality of life. Ann Thorac Surg. 2007;84(3):775–80. Discussion 780–1.
24. Olsson C, Franco-Cereceda A.Health-related quality of life in thoracic aortic disease: part II.After surgery on the proximal (root, ascending, arch) aorta. Aorta Stamford Conn. 2013;1(3):162–70.
25. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.
26. Adam U, Habazettl H, Graefe K, Kuppe H, Wundram M, Kurz SD.Health-related quality of life of patients after surgery for acute Type A aortic dissection. Interact Cardiovasc Thorac Surg. 2018;27(1):48–53.
27. Campbell-Lloyd AJ, Mundy J, Pinto N, Wood A, Beller E, Strahan S, etal. Contemporary results fol­lowing surgical repair of acute type A aortic dissec­tion (AAAD): a single centre experience. Heart Lung Circ. 2010;19(11):665–72.
28. Endlich M, Hamiko M, Gestrich C, Probst C, Mellert F, Winkler K, etal. Long-term outcome and quality of life in aortic type A dissection survivors. Thorac Cardiovasc Surg. 2016;64(2):91–9.
29. Ghazy T, Eraqi M, Mahlmann A, Hegelmann H, Matschke K, Kappert U, etal. Quality of life after sur­gery for stanford type a aortic dissection: inuences of different operative strategies. Heart Surg Forum. 2017;20(3):E102–6.
30. Kamenskaya O, Klinkova A, Loginova I, Chernyavskiy A, Sirota D, Lomivorotov VV, et al. Health-related quality of life one year after surgical treatment of the type I chronic aortic dissection. Int Angiol J Int Union Angiol. 2019;38(1):46–53.
31. Nakamura Y, Tagusari O, Ichikawa Y, Morita A. Impact of immediate aortic repair on early and midterm neurologic status in patients with acute type a aortic dissection complicated by cerebral malperfu­sion. Ann Thorac Surg. 2011;92(1):336–8.
32. Myrmel T, Trimarchi S, Rampoldi V.Cardiovascular surgery in the initial treatment of aortic dissec­tion and acute aortic syndromes. In: Eagle KA, Baliga RR, Isselbacher EM, Nienaber CA, edi­tors. Aortic dissection and related syndromes [Internet]. Boston, MA: Springer US; 2007 [cited 2020 Jan 27]. p. 167–90. (Developments in Cardiovascular Medicine). Available from: https://
doi.org/10.1007/978- 0- 387- 36001- 0_9.
33. Uchida N, Katayama K, Takahashi S, Sueda T. Endovascular stent grafting of the downstream aorta after complete arch replacement using the fro­zen elephant trunk technique for acute type A aortic dissection. Eur J Cardiothorac Surg. 2013;43(1):196.
34. Clouse WD, Hallett JW, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ. Improved prognosis of tho­racic aortic aneurysms: a population-based study. JAMA. 1998;280(22):1926–9.
35. Frederick JR, Woo YJ. Thoracoabdominal aortic aneurysm. Ann Cardiothorac Surg. 2012;1(3):277–85.
36. Coroneos CJ, Mastracci TM, Barlas S, Cinà CS.The effect of thoracoabdominal aneurysm repair on qual­ity of life. J Vasc Surg. 2009;50(2):251–5.
37. Crawford RS, Pedraza JD, Chung TK, Corey M, Conrad MF, Cambria RP. Functional outcome after thoracoabdominal aneurysm repair. J Vasc Surg. 2008;48(4):828–35.
80
M. K. H. Tan et al.
38. Di Luozzo G, Shirali AS, Varghese R, Lin H-M, Weiss AJ, Bischoff MS, etal. Quality of life and survival of septuagenarians and octogenarians after repair of descending and thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg. 2013;145(2):378–84.
39. Eide TMO, Romundstad P, Klepstad P, Myhre HO. Health-related quality of life in long term­survivors of thoracoabdominal aortic aneurysm repair. J Vasc Nurs. 2005;23(3):88–94.
40. Ghanta RK, Green SY, Price MD, Arredondo CC, Wainwright D, Preventza O, etal. Midterm survival and quality of life after extent ii thoracoabdominal aortic repair in Marfan syndrome. Ann Thorac Surg. 2016;101(4):1402–9. Discussion 1409.
41. Zierer A, Melby SJ, Lubahn JG, Sicard GA, Damiano RJ, Moon MR. Elective surgery for thoracic aortic aneurysms: late functional status and quality of life. Ann Thorac Surg. 2006;82(2):573–8.
42. Dick F, Hinder D, Immer FF, Hirzel C, Carrel TP, Schmidli J. Outcome and quality of life after surgi­cal and endovascular treatment of descending aortic lesions. Ann Thorac Surg. 2008;85(5):1605–12.
43. Kärkkäinen JM, Sandri G d A, Tenorio ER, Macedo TA, Hofer J, Gloviczki P, etal. Prospective assess­ment of health-related quality of life after endovas­cular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts. J Vasc Surg. 2019;69(5):1356–66.
44. Klocker J, Koell A, Erlmeier M, Goebel G, Jaschke W, Fraedrich G.Ischemia and functional status of the left arm and quality of life after left subclavian artery coverage during stent grafting of thoracic aortic dis­eases. J Vasc Surg. 2014;60(1):64–9.
45. McBride CL, Dubose JJ, Miller CC, Perlick AP, Charlton-Ouw KM, Estrera AL, etal. Intentional left subclavian artery coverage during thoracic endovas­cular aortic repair for traumatic aortic injury. J Vasc Surg. 2015;61(1):73–9.
46. Ouriel K, Greenberg RK. Endovascular treat­ment of thoracic aortic aneurysms. J Card Surg. 2003;18(5):455–63.
47. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM. Endovascular versus open repair of abdomi­nal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet. 2016;388(10058):2366–74.
48. Rampoldi V, Trimarchi S, Eagle KA, Nienaber CA, Oh JK, Bossone E, etal. Simple risk models to predict surgical mortality in acute type A aortic dissection: the International Registry of Acute Aortic Dissection score. Ann Thorac Surg. 2007;83(1):55–61.
49. Shah PJ, Estrera AL, Miller CC, Lee T-Y, Irani AD, Meada R, etal. Analysis of ascending and transverse aortic arch repair in octogenarians. Ann Thorac Surg. 2008;86(3):774–9.
50. Jussli-Melchers J, Panholzer B, Friedrich C, Broch O, Renner J, Schöttler J, et al. Long-term outcome and quality of life following emergency surgery for
acute aortic dissection type A: a comparison between young and elderly adults. Eur J Cardiothorac Surg. 2017;51(3):465–71.
51. Kurazumi H, Mikamo A, Kudo T, Suzuki R, Takahashi M, Shirasawa B, et al. Aortic arch surgery in octo­genarians: is it justied? Eur J Cardiothorac Surg. 2014;46(4):672–7.
52. Oda K, Hata M, Kawatsu S, Adachi O, Yamaya K, Saiki Y, etal. Quality of life in elderly patients follow­ing thoracic aortic surgery. Jpn J Thorac Cardiovasc Surg. 2004;52(11):515–23.
53. Santini F, Montalbano G, Messina A, D’Onofrio A, Casali G, Viscardi F, et al. Survival and quality of life after repair of acute type A aortic dissection in patients aged 75 years and older justify intervention. Eur J Cardiothorac Surg. 2006;29(3):386–91.
54. Immer FF, Lippeck C, Barmettler H, Berdat PA, Eckstein FS, Kipfer B, et al. Surgery for aortic and peripheral vascular disease-improvement of quality of life after surgery on the thoracic aorta: effect of ante­grade cerebral perfusion and short duration of deep hypothermic. Circulation. 2004;110(11):II250.
55. Immer FF, Moser B, Krähenbühl ES, Englberger L, Stalder M, Eckstein FS, etal. Arterial access through the right subclavian artery in surgery of the aortic arch improves neurologic outcome and mid-term quality of life. Ann Thorac Surg. 2008;85(5):1614–8. Discussion 1618.
56. Kobuch R, Schelker E, Schmid C, Hirt S, Amann M, Diez C. Quality of life following surgery of ascending aorta and aortic arch with selective ante­grade cerebral perfusion. Thorac Cardiovasc Surg. 2012;60(8):496–500.
57. Krähenbühl ES, Immer FF, Stalder M, Englberger L, Eckstein FS, Carrel TP.Temporary neurological dys­function after surgery of the thoracic aorta: a predictor of poor outcome and impaired quality of life. Eur J Cardiothorac Surg. 2008;33(6):1025–9.
58. Krähenbühl ES, Clément M, Reineke D, Czerny M, Stalder M, Aymard T, etal. Antegrade cerebral protec­tion in thoracic aortic surgery: lessons from the past decade. Eur J Cardiothorac Surg. 2010;38(1):46–51.
59. Stewart JA, Ilkka VH, Jokinen JJ, Vakkuri AP, Suojaranta RT, Wennervirta J, etal. Long-term survival and quality of life after hypothermic circulatory arrest
60. Zhao R, Cui Q, Yu S-Q, Sun G-C, Wang H-B, Jin Z-X, etal. Antegrade cerebral perfusion during deep hypo­thermia circulatory arrest attenuates the apoptosis of neurons in porcine hippocampus. Heart Surg Forum. 2009 Aug;12(4):E219–24.
61. Salazar JD, Coleman RD, Grifth S, McNeil JD, Steigelman M, Young H, et al. Selective cerebral perfusion: real-time evidence of brain oxygen and energy metabolism preservation. Ann Thorac Surg. 2009;88(1):162–9.
62. Salazar J, Coleman R, Grifth S, McNeil J, Young H, Calhoon J, et al. Brain preservation with selec­tive cerebral perfusion for operations requiring cir-
4 Thoracic Aortic Surgery
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
81
culatory arrest: protection at 25 degrees C is similar to 18 degrees C with shorter operating times. Eur J Cardiothorac Surg. 2009;36(3):524–31.
63. Korteland NM, Kluin J, Klautz RJM, Roos-Hesselink JW, Versteegh MIM, Bogers AJJC, etal. Cardiologist and cardiac surgeon view on decision-making in pros­thetic aortic valve selection: does profession matter? Neth Heart J. 2014;22(7):336–43.
64. Williams K, Sansoni J, Morris D, Grootemaat P, Thompson C.Patient-reported outcome measures. 91.
65. Kurrst V, Mokráček A, Krupauerová M, Čanádyová J, Bulava A, Pešl L, et al. Health-related quality of life after cardiac surgery– the effects of age, preop­erative conditions and postoperative complications. J Cardiothorac Surg. 2014;9(1):46.
66. Koch CG, Khandwala F, Estafanous FG, Loop FD, Blackstone EH.Impact of prosthesis–patient size on functional recovery after aortic valve replacement. Circulation. 2005;111(24):3221–9.
67. de Heer F, Gökalp AL, Kluin J, Takkenberg JJM. Measuring what matters to the patient: health related quality of life after aortic valve and thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2019 Jan;67(1):37–43.
68. Ross JK, Diwell AE, Marsh J, Monro JL, Barker DJ. Wessex cardiac surgery follow-up survey: the quality of life after operation. Thorax. 1978;33(1):3–9.
69. McNamara RL, Spatz ES, Kelley TA, Stowell CJ, Beltrame J, Heidenreich P, et al. Standardized out­come measurement for patients with coronary artery disease: consensus from the international consortium
for health outcomes measurement (ICHOM). J Am Heart Assoc. 2015;4(5):e001767.
70. Tan MKH, Wong JKL, Bakrania K, Abdullahi Y, Harling L, Casula R, etal. Can activity monitors pre­dict outcomes in patients with heart failure? A sys­tematic review. Eur Heart J Qual Care Clin Outcomes. 2019;5(1):11–21.
71. Rowlands AV, Olds TS, Hillsdon M, Pulsford R, Hurst TL, Eston RG, et al. Assessing sedentary behav­ior with the GENEActiv: introducing the sedentary sphere. Med Sci Sports Exerc. 2014;46(6):1235–47.
72. Jarral OA, Tan MKH, Salmasi MY, Pirola S, Pepper JR, O’Regan DP, etal. Phase-contrast magnetic reso­nance imaging and computational uid dynamics assessment of thoracic aorta blood ow: a literature review. Eur J Cardiothorac Surg [Internet]. [cited 2020 Jan 28]. Available from: https://academic.
oup.com/ejcts/advance- article/doi/10.1093/ejcts/ ezz280/5602446.
73. Kidher E, Cheng Z, Jarral OA, O’Regan DP, Xu XY, Athanasiou T. In-vivo assessment of the morphology and hemodynamic functions of the BioValsalva™ composite valve-conduit graft using cardiac magnetic resonance imaging and computational modelling technology. J Cardiothorac Surg. 2014;9:193.
74. Kidher E, Harling L, Nihoyannopoulos P, Shenker N, Ashraan H, Francis DP, etal. High aortic pulse wave velocity is associated with poor quality of life in surgi­cal aortic valve stenosis patients. Interact Cardiovasc Thorac Surg. 2014;19(2):189–97.